| Literature DB >> 33480459 |
Yue Zhang1,2, Anila Khalique1, Xinchen Du1, Zhanxia Gao1,3, Jin Wu1,4, Xiangyun Zhang1, Ran Zhang1, Zhiyuan Sun1, Qiqi Liu1, Zhelong Xu2, Adam C Midgley1, Lianyong Wang1, Xiyun Yan1,4,5, Jie Zhuang1,3,4, Deling Kong1, Xinglu Huang1,4.
Abstract
Development of enzyme mimics for the scavenging of excessive mitochondrial superoxide (O2 •- ) can serve as an effective strategy in the treatment of many diseases. Here, protein reconstruction technology and nanotechnology is taken advantage of to biomimetically create an artificial hybrid nanozyme. These nanozymes consist of ferritin-heavy-chain-based protein as the enzyme scaffold and a metal nanoparticle core as the enzyme active center. This artificial cascade nanozyme possesses superoxide dismutase- and catalase-like activities and also targets mitochondria by overcoming multiple biological barriers. Using cardiac ischemia-reperfusion animal models, the protective advantages of the hybrid nanozymes are demonstrated in vivo during mitochondrial oxidative injury and in the recovery of heart functionality following infarction via systemic delivery and localized release from adhesive hydrogels (i.e., cardiac patch), respectively. This study illustrates a de novo design strategy in the development of enzyme mimics and provides a promising therapeutic option for alleviating oxidative damage in regenerative medicine.Entities:
Keywords: de novo design; mitochondria; nanozymes; protein scaffolds; superoxide scavengers
Year: 2021 PMID: 33480459 DOI: 10.1002/adma.202006570
Source DB: PubMed Journal: Adv Mater ISSN: 0935-9648 Impact factor: 30.849